Although inhibiting JNK1 in hematopoietic cells does not affect adiposity, it is sufficient to reduce the inflammation brought on by obesity, which has positive metabolic consequences [130]. Here, MAPK8 is linked to obesity due to melanocortin 4 receptor deficiency.